Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-24 @ 11:39 PM
NCT ID: NCT05494151
Eligibility Criteria: Inclusion Criteria: * Age \>25 years * Hospitalization for acute myocardial infarction (AMI) with or without ST elevation (based on Fourth Universal Definition of Myocardial Infarction) within the previous 4 weeks * Coronary angiography before or after hospitalization for AMI, in which at least one stenosis \>50% in a major epicardial coronary artery (left anterior descending artery, left circumflex artery, right coronary artery) or a branch thereof with a diameter of at least 2 mm was observed. Exclusion Criteria: * Inability or refusal to provide informed consent * Age \>80 years * History of hospitalization due to AMI prior to the present AMI * History of coronary revascularization prior to the present AMI AMI * Previous coronary angiography (prior to the present AMI) showing \>50% stenosis in a major epicardial coronary artery Exclusion Criteria for SMuRF-less patients group only: * Known history of hypertension and/or antihypertensive treatment prior to AMI * Use of tobacco products on a systematic basis for up to \<12 months before AMI * History of diabetes mellitus type 1 or 2 and/or treatment with antidiabetic tablets or insulin before AMI or diagnosis of diabetes mellitus based on HbA1c during AMI hospitalization * Known hypercholesterolemia (total chol \>200 mg/dl / LDLc \>150 mg/dl) or treatment with statins or PCSK9is, before AMI
Healthy Volunteers: False
Sex: ALL
Minimum Age: 25 Years
Maximum Age: 80 Years
Study: NCT05494151
Study Brief:
Protocol Section: NCT05494151